Chiara Di Pace

670 total citations
16 papers, 499 citations indexed

About

Chiara Di Pace is a scholar working on Psychiatry and Mental health, Pharmacology and Surgery. According to data from OpenAlex, Chiara Di Pace has authored 16 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 7 papers in Pharmacology and 2 papers in Surgery. Recurrent topics in Chiara Di Pace's work include Schizophrenia research and treatment (12 papers), Treatment of Major Depression (7 papers) and Bipolar Disorder and Treatment (5 papers). Chiara Di Pace is often cited by papers focused on Schizophrenia research and treatment (12 papers), Treatment of Major Depression (7 papers) and Bipolar Disorder and Treatment (5 papers). Chiara Di Pace collaborates with scholars based in Italy, United Kingdom and United States. Chiara Di Pace's co-authors include Silvia Paletta, Massimo Carlo Mauri, A. Carlo Altamura, Alessandro Colasanti, M. Maffini, Montserrat Maurí, Filippo Dragogna, Giovanna Cirnigliaro, Alfredo Carlo Altamura and Isabel Valli and has published in prestigious journals such as British Journal of Cancer, Clinical Pharmacokinetics and Journal of Clinical Psychopharmacology.

In The Last Decade

Chiara Di Pace

16 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Di Pace Italy 10 284 96 71 71 48 16 499
Megan J. Ehret United States 12 186 0.7× 101 1.1× 63 0.9× 73 1.0× 49 1.0× 23 422
Paulien Ravenstijn United States 13 304 1.1× 89 0.9× 95 1.3× 58 0.8× 91 1.9× 32 699
Nevena Divac Serbia 13 229 0.8× 83 0.9× 114 1.6× 93 1.3× 102 2.1× 38 730
Silvia Paletta Italy 12 382 1.3× 128 1.3× 70 1.0× 96 1.4× 55 1.1× 29 673
James Ermer United States 16 327 1.2× 90 0.9× 65 0.9× 156 2.2× 106 2.2× 45 656
Wei‐Che Chiu Taiwan 14 226 0.8× 40 0.4× 91 1.3× 42 0.6× 43 0.9× 47 661
L.S. Volonteri Italy 10 304 1.1× 94 1.0× 50 0.7× 74 1.0× 46 1.0× 17 479
Ahmed Elkashef United States 8 344 1.2× 56 0.6× 44 0.6× 88 1.2× 39 0.8× 23 584
Tonya Quinlan United States 12 183 0.6× 120 1.3× 57 0.8× 21 0.3× 45 0.9× 16 387
Maria Teresa Cruz Lourenço Canada 12 177 0.6× 59 0.6× 99 1.4× 43 0.6× 27 0.6× 19 552

Countries citing papers authored by Chiara Di Pace

Since Specialization
Citations

This map shows the geographic impact of Chiara Di Pace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Di Pace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Di Pace more than expected).

Fields of papers citing papers by Chiara Di Pace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Di Pace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Di Pace. The network helps show where Chiara Di Pace may publish in the future.

Co-authorship network of co-authors of Chiara Di Pace

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Di Pace. A scholar is included among the top collaborators of Chiara Di Pace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Di Pace. Chiara Di Pace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Mauri, Massimo Carlo, et al.. (2021). The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly. Journal of Clinical Psychopharmacology. 42(1). 23–30. 6 indexed citations
2.
Mauri, Massimo Carlo, et al.. (2020). Paliperidone LAI and Aripiprazole LAI Plasma Level Monitoring in the Prophylaxis of Bipolar Disorder Type I with Manic Predominance. Pharmacopsychiatry. 53(5). 209–219. 11 indexed citations
3.
Mauri, Massimo Carlo, Giovanna Cirnigliaro, Chiara Di Pace, et al.. (2019). Aggressiveness and violence in psychiatric patients: a clinical or social paradigm?. CNS Spectrums. 24(5). 564–573. 11 indexed citations
4.
Fiorentini, A., Chiara Rovera, Alice Caldiroli, et al.. (2018). Efficacy of oral trazodone slow release following intravenous administration in depressed patients: a naturalistic study. Rivista di psichiatria. 53(5). 261–266. 1 indexed citations
5.
Mauri, Massimo Carlo, Silvia Paletta, Chiara Di Pace, et al.. (2018). Clinical Pharmacokinetics of Atypical Antipsychotics: An Update. Clinical Pharmacokinetics. 57(12). 1493–1528. 126 indexed citations
6.
Baldelli, Sara, Massimo Carlo Mauri, Chiara Di Pace, et al.. (2018). Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable Formulation. Journal of Clinical Psychopharmacology. 38(4). 365–369. 9 indexed citations
7.
Mauri, Massimo Carlo, et al.. (2017). Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up. Asian Journal of Psychiatry. 29. 117–122. 26 indexed citations
8.
Altamura, A. Carlo, Giuseppe Delvecchio, Silvia Paletta, et al.. (2017). Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study. Psychiatry Research Neuroimaging. 261. 80–84. 9 indexed citations
9.
Mauri, Massimo Carlo, et al.. (2017). Paliperidone for the treatment of schizophrenia and schizoaffective disorders - a drug safety evaluation. Expert Opinion on Drug Safety. 16(3). 365–379. 24 indexed citations
10.
Mauri, Massimo Carlo, Silvia Paletta, Chiara Di Pace, et al.. (2017). Paliperidone Long-Acting Plasma Level Monitoring and a New Method of Evaluation of Clinical Stability. Pharmacopsychiatry. 50(4). 145–151. 10 indexed citations
11.
Rovera, Chiara, Massimo Carlo Mauri, Chiara Di Pace, et al.. (2016). Duloxetine in elderly major depression disorder: effectiveness and drug plasma level evaluation. Human Psychopharmacology Clinical and Experimental. 31(5). 349–355. 5 indexed citations
12.
Pace, Chiara Di, et al.. (2015). P.3.d.076 Paliperidone “long-acting” and plasma levels along 1 year of maintenance therapy in schizophrenia and schizoaffective disorder. European Neuropsychopharmacology. 25. S525–S525. 3 indexed citations
13.
Mauri, Massimo Carlo, M. Maffini, Chiara Di Pace, et al.. (2014). “Long-acting” olanzapine in maintenance therapy of schizophrenia: A study with plasma levels. International Journal of Psychiatry in Clinical Practice. 19(2). 99–105. 12 indexed citations
14.
Maurí, Montserrat, Silvia Paletta, M. Maffini, et al.. (2014). Review article: CLINICAL PHARMACOLOGY OF ATYPICAL ANTIPSYCHOTICS: AN UPDATE. 1 indexed citations
15.
Maurí, Montserrat, Silvia Paletta, M. Maffini, et al.. (2014). Clinical pharmacology of atypical antipsychotics: an update. PubMed. 13. 1163–91. 208 indexed citations
16.
Achille, Alberto, et al.. (1998). Chromosome 5 allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. British Journal of Cancer. 78(12). 1653–1660. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026